Ampio seeks to raise $6.75M through stock sale

Ampio seeks to raise $6.75M through stock sale

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced it has entered into a securities purchase agreement with investors for the registered sale of approximately$6.75... Read More

Tuesday October 17, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals

Ampio Pharmaceuticals announces allowance of composition and methods patent for Ampion

Ampio Pharmaceuticals announces allowance of composition and methods patent for Ampion

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) today announced the allowance of an important composition and methods patent in the U.S. complimenting a series of patents on Ampion... Read More

Tuesday August 8, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Michael Macaluso, Ampion

Ampio appoints Tom Chilcott as interim CEO

Ampio appoints Tom Chilcott as interim CEO

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) today announced it has not renewed the employment agreement of Gregory Gould , Ampio's chief financial officer, which expired on ... Read More

Tuesday June 13, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Gregory Gould, Tom Chilcott, Aytu BioScience

Ampio Pharmaceuticals selling $6.3M in stock to fund Ampion clinical tests

Ampio Pharmaceuticals selling $6.3M in stock to fund Ampion clinical tests

ENGLEWOOD -- A mpio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announced it has entered into a securities purchase agreement with investors providing for the registered sale of approximately... Read More

Monday June 5, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion

Ampio initiates pivotal Ampion osteoarthritis trial

Ampio initiates pivotal Ampion osteoarthritis trial

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) announced it has begun a single injection study to meet the unmet medical need of treating the severe pain and loss of function... Read More

Monday May 1, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Dr. David Bar-Or, Chris Ehrlich, Michael Macaluso

Ampio: FDA discussions continue on best path forward for Ampion

Ampio: FDA discussions continue on best path forward for Ampion

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced it is continuing discussions with the CBER Division of the FDA to determine the best path forward to obtain a Biological... Read More

Thursday November 10, 2016 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Michael Macaluso, FDA

Ampio Pharmaceuticals announces stock sale to investor to raise $3.75M

Ampio Pharmaceuticals announces stock sale to investor to raise $3.75M

ENGLEWOOD -- Ampio Pharmaceuticals , Inc. (NYSE MKT: AMPE) announced it has entered into a securities purchase agreement with an institutional investor providing for the registered sale of... Read More

Thursday September 1, 2016 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion